Ireland· IE-PA-PA0749/199/002
Gabitril 10 mg film-coated tablets
A tiagabine product containing tiagabine, registered in Ireland by Teva Pharma B.V.. The same ATC class is registered in 9 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Tiagabine is registered in 9 of 19 countries.
Countries holding a registration under ATC N03AG06 (tiagabine), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Tiagabine · ATC N03AG06
9 / 19 countries
- Belgiumprice
- Finlandprice
- Franceprice
- Ireland
- Italyprice
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tiagabine costs, country by country.
Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tiagabine · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- IT Italy$3.98
- FR France$3.35
The record
At a glance
HPRA (Ireland)- Active substance
- Tiagabine
- Manufacturer
- Teva Pharma B.V.
- Country
- Ireland (IE)
- ATC code
- N03AG06
- ATC class
- Tiagabine
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0749/199/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
163 interactions on record for tiagabine.
Graded by severity as the source publishes them — 92 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tiagabine · interactions on record
163 records
- 92 moderate
- 46 info
Most severe, free to view
- MetoclopramideA03FA01moderate
- DiphenhydraminA04AB05moderate
- DronabinolA04AD10moderate
- NabiloneA04AD11moderate
25 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tiagabine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumGabitril 10 mgTeva
- SpainGABITRIL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULATeva B.V.
- FinlandGabitrilCephalon France
- FranceGABITRIL 10 mg, comprimé pelliculéTEVA PHARMA (PAYS-BAS)
- PolandGabitrilTeva Pharmaceuticals Polska Sp. z o.o.
- United KingdomGabitril 10mg tabletsTeva UK Ltd
- United StatesTiagabine HydrochlorideNovadoz Pharmaceuticals LLC
- ItalyGABITRIL*50 cpr rivestite 10 mgTEVA ITALIA Srl
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Belgium · Gabitril
- Spain · Gabitril
- France · Gabitril
- United Kingdom (Northern Ireland) · Gabitril
- Italy · Gabitril
- Luxembourg · Gabitril
- Poland · Gabitril
- Portugal · Gabitril
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/78c5cebc-5b1c-4322-9d25-6e1310934e4e GET /v1/drugs/78c5cebc-5b1c-4322-9d25-6e1310934e4e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"N03AG",
"N03AG06"
],
"strength": null,
"pa_number": "PA0749/199/002",
"substances": [
"Tiagabine"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "07/03/1997",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about tiagabine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.